Anthony is a seasoned healthcare executive with over two decades of experience, including leadership roles as the Chief Administrative Officer for 20 Community Hospital Outpatient Clinics in Southern California. His expertise spans strategic growth initiatives, acquisition integrations, patient-centered care enhancements, and turnaround projects. Dr. Russell holds double board certifications in pediatrics and clinical informatics and has held senior and executive positions at esteemed healthcare systems in California. He received his education and training at Medical University of South Carolina, Johns Hopkins University, University of Massachusetts (Amherst), and UCSF. Currently, Dr Russell serves as Chairman on two private healthcare boards, participates on the two medical advisory boards, and invests in multiple private equity holdings. Anthony shall be heading our EEE Corporate Group Delaware branch in the West Coast from our offices in Los Angeles, while Charles continues to head our UK operations.

Charles serves as Head of UK Operations and deploys his many years’ experience to ensure appropriate strategies and business model. Charles is a business valuation specialist and ensures best practice with IP and market opportunity taken into account. Charles has an MBA (with award) from Henley Business Management School and 20 years’ experience in valuing and turning around promising entities. Additionally, he has the experience of operational control of organizations of £100m on the one hand to bringing about significant growth of small fledgling groups on the other.

Dr. Eswara serves as EEE Medical Advisory Committee Member specializing in Urology and Prostate Cancer. He is the Chief of Urology of St. Elizabeth’s Medical Center, Boston University School of Medicine and Fellowship Director for their program in Robotics and Reconstruction. He is one of the only physicians in Boston with expertise in urologic trauma and reconstruction, including urethral reconstruction, artificial urinary sphincters, penile prostheses, male and female slings, urinary diversions, sacral neuromodulation, and other trauma and reconstructions of the genitourinary system. In addition, he treats BPH, kidney stones, neurogenic bladder, penile and urethral cancer, renal and bladder cancer, prostate cancer, kidney cancer, testis cancer, male and female voiding dysfunction, urethral stricture disease, ureteral strictures, urinary diversions, urinary tract fistulae and continent urinary diversions. Dr. Eswara joined St. Elizabeth’s from Brigham and Women’s Hospital and prior to that, he was an attending surgeon at Massachusetts General Hospital and Barnes-Jewish Hospital in St. Louis. He is board certified in urology. Dr. Eswara completed a fellowship in urologic trauma and reconstruction at Washington University School of Medicine. He earned his medical degree at Harvard-MIT Health Sciences and Technology and Harvard Medical School. Dr. Eswara serves as an ecosystem partner for EEE, leading exclusively on Urologic Trauma, Reconstruction, and Urologic Oncology.

Professor Hayee serves as EEE Medical Advisory Committee Member specializing in Gastroenterology. He is a Consultant Gastroenterologist at King’s College Hospital and has been Chief of Service since 2015. He trained at Guy’s Hospital (GKT Medical School), graduating in 1999, and was appointed a Fellow of the Royal College of Physicians in 2015. His PhD, awarded in 2010, examined the role of innate immunity and neutrophil function in Crohn’s disease. In 2011, he was awarded a travelling fellowship to Yokohama, Japan, to study advanced endoscopic techniques with Professors Haruhiro Inoue and Shin-ei Kudo. He is a Professor in Gastroenterology at King’s College London and maintains an active research interest, supervising several PhD fellows and basic scientists. He is nationally-accredited for bowel cancer screening colonoscopy and has specialist interests in inflammatory bowel disease (IBD) and high-quality endoscopy, supported by NIHR project grant funding. He led development of the specialist IBD service from 2012-2017, being shortlisted for an HSJ Excellence in Healthcare award in 2017. Professor Hayee is a member of the British Society of Gastroenterology (for whom he serves as a member of the IBD section committee), the American Gastroenterological Association, the European Crohn’s and Colitis Organisation, the American and European Societies for Gastrointestinal Endoscopy and the Association for Bariatric Endoscopy. He is Clinical Lead for Gastroenterology, Training Lead for Endoscopy, and Co-director of the King’s Institute of Therapeutic Endoscopy. He combines his two main interests (IBD and Endoscopy) in clinical service and research. He has projects investigating graft versus host disease of the gut, cystic fibrosis, chromoendoscopy for colitis surveillance, and has an active interest in novel treatments for IBD. Professor Hayee serves as an ecosystem partner for EEE, leading exclusively on Gastroenterology field.

Major General Dr. Elder Granger serves as EEE/HJF Advisory Committee Member specializing in health plan policy. Prior to his retirement from the US Army in 2009, MG Granger served as the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, DC. In that role, he was the principal advisor on health plan policy and performance at the Department of Defense. His experience, background, training, and expertise has required the building of strong, value-based relationships. He uses clear guidelines to assess and determine “best value” and determines a process to ensure clear requirements and criteria to manage relationships to measurable, accountable outcomes. MG Granger oversaw the acquisition, operation, and integration of TRICARE/DOD’s managed care program within the Military Health System, leading a staff of 1,800 in planning, budgeting, and executing a $22.5 Billion Defense Health Program. Prior to joining TRICARE Management Activity, MG Granger led the largest U.S. and multi-national battlefield health system in our recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. He has led at every level of the Army Medical Department, with previous assignments across the United States, Europe, and Iraq. MG Granger has received numerous awards, decorations, and honors, including the Defense Superior Service Medal, the Legion of Merit with three oak leaf clusters, the Bronze Star Medal, and the Meritorious Service Medal with four oak leaf clusters. He is board-certified by the American Board of Internal Medicine and the Board of Hematology and Oncology, certified Physician Executive by the Certifying Commission in Medical Management, certified by the American College of Healthcare Executives, and Certified in Medical Quality by the American Board of Medical Quality. CERT-certificate in Cybersecurity Oversight from Carnegie Mellon University, certified in Healthcare Compliance by HCCA and is a certified Compliance Officer by AAPC. MG Granger serves as an ecosystem partner for EEE, leading on Military Market Strategies.

Mr. Augustenborg serves as EEE Intelligence Advisor. He served in the CIA’s Clandestine Service and Directorate of Operations for 35 years reaching the highest ranks of the Senior Intelligence Service. His last position was Chief of CIA’s largest domestic Station where he worked closely with the US private sector and US Law Enforcement. He also served as Chief of Station in CIA’s flag ship locations in both East Asia and Latin America. While posted in Washington DC, he held positions as Chief of Operations for CIA’s Counter Intelligence Center and Chief of Operations for Latin America. Mr. Augustenborg’s eight foreign diplomatic postings included locations in the former Soviet Union, Europe, Asia, and Latin America. Prior to entering the CIA, Mr. Augustenborg was a Los Angeles Police Officer where he worked undercover in LAPD’s Public Disorder Intelligence Division, as well as serving in multiple uniform Divisions, Public Affairs and Juvenile Division. Mr. Augustenborg holds a BA Degree from the University of Southern California in International Relations and Social Studies, and a MA Degree from Pepperdine University in Public Communication. He also completed a year of study at University College, London England at the Center for International Conflict Resolution. Mr. Augustenborg speaks Spanish and has a working knowledge of Russian, Italian and Hungarian. A recipient of the CIA Career Intelligence Medal, Mr. Augustenborg chaired the CIA’s leadership and teamwork training program for high performance officers and served on numerous strategic planning and promotion boards for the Intelligence Community. He also worked closely with many foreign intelligence and security services covering four continents where he provided training, operational assistance, logistical support and leadership for joint intelligence programs. Upon entering the private sector Mr. Augustenborg founded and is the CEO of Novus Intelligence, LLC. This company provides a full range of risk mitigation services including cyber security, due diligence investigations, and social media and dark web monitoring for large corporations, Law Firms, Financial Institutions and Family Offices. In addition, Mr. Augustenborg is a Senior Advisor for the Chairman and CEO of Starr Companies Insurance and Global Investments, as well as Teneo global consulting services. He also serves on several Advisory Boards including Liberty BioSecurity. Mr. Augustenborg serves as an ecosystem partner for EEE, leading on Intelligence and Security matters.

Mr. Teng serves as EEE IP Advisory Member. He works across a wide spectrum of industrial design and engineering subject matters, using his broad technical expertise and IP consultancy skills to advise clients on all phases of their business from production to end product to commercialization. In particular Mr. Teng has considerable experience in advising on design and patent matters for medical devices and scientific instrumentation. His expertise ranges from start-ups seeking investment to SMEs needing a trusted IP advisor to multinationals requiring all-encompassing IP strategy and management. His work includes drafting and prosecution of patent and design applications, patent and design portfolio management, advising on freedom to operate issues, and strategic IP planning. Mr. Teng serves as an ecosystem partner for EEE, leading on IP strategy and management.

Mr. Whitaker serves as Chief Technology Officer at EEE. Over the past 15 years, he has had the privilege of leading a dynamic and dedicated team of professionals, together achieving an impressive milestone of 1,000 successful projects. He has led and completed many successful projects for the US Government in DC. He is passionate about harnessing the power of technology to create meaningful and transformational digital experiences. As a leader, he is committed to fostering an environment that encourages innovation, collaboration, and continuous learning. He believes in staying at the forefront of technological advancements and trends, always looking for new ways to refine the craft and deliver unparalleled results for clients and drive EEE’s missions forward with diligence and vigilance while protecting the client’s and EEE’s proprietary data and security with his forward planning and execution.

Dr. Lopez-Correa serves as EEE Genomics Advisor specializing in genomics and its transformative applications in life sciences in Canada and internationally. As a Chief Scientific Officer at Genome Canada, she was instrumental in developing competitive teams for research and innovation initiatives raising the profile of Canadian genomics on the global stage. Recently, as the Executive Director of the Canadian COVID19 Genomics Network, she led a $40M initiative to advance the use of genomics to understand and control the COVID19 pandemic. Prior to that, she has played advisory roles at the European Commission, Innovative Medicine Initiatives, the World Health Organization, the World Economic Forum and other private and public sector entities working in the equitable and global implementation of genomics technologies. Dr. Lopez-Correa’s work has been recognized with several awards. Among others, in 2017 the Canadian Senate 150th Anniversary Medal, in 2013 the National Order of Merit from Colombia.